Introduction
============

By 2030, there will be 72.1 million people ≥ 65 years of age, representing 19% of the U.S. population, according to the Department of Health and Human Services (U.S. Department of Health and Human Services 2014). The aging process reduces physiological capacity, which makes the elderly more susceptible to many health threats. There is compelling evidence that short- and long-term exposure to ambient air pollution, especially due to traffic, adversely affect lung function ([@r6]). However, most of the studies have focused on children. Although research examining the effects of air pollution on forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV~1~) in the elderly is warranted ([@r35]), to our knowledge, these associations have not yet been investigated.

The underlying mechanisms linking air pollution and lung function are not fully characterized. Lung function has been shown to be strongly heritable, part of which is controlled by inflammatory genes ([@r45]). Consistent with this observation, many studies have reported associations between lung function and polymorphisms within genes coding for inflammatory, oxidative stress and innate immunity mediators, such as *CRP* ([@r45]), *IL-6* ([@r14]), *iNOS* ([@r19]), or *TLRs* ([@r7]). Other studies have reported stronger associations between air pollution and pulmonary outcomes in subjects with such polymorphisms ([@r20]; [@r49]). There is increasing evidence that epigenetic mechanisms may interact with genetic variation to influence disease pathogenesis and the inheritance of disease traits.

Methylation in CpG-rich regions within gene promoters is commonly associated with repressed gene expression, because it may impede the binding of transcription factors ([@r13]). Studies in humans have reported associations between blood DNA methylation and cardiovascular diseases ([@r44]), respiratory health ([@r24]), and survival ([@r3]).

We hypothesized that short-term exposure to traffic-related air pollutants would be associated with lung function decrease in a cohort of elderly men. Subsequently, we examined whether methylation level within or near the promoter region of selected genes related to inflammation, immunity, endothelial function, and oxidative stress may be a susceptibility factor for lung function impairment.

Methods
=======

*Study population and pulmonary health*. Our study included 776 elderly men living in the Boston, Massachusetts, area, enrolled in the Normative Aging Study cohort ([@r5]). Participants provided written informed consent, and the study was approved by the institutional review boards of all participating institutions. Subjects completed one to four clinical examinations between 1999 and 2009. Each visit took place in the morning after an overnight fast and smoking abstinence. At each visit, information about medication use (corticosteroids, sympathomimetic α and β, anticholinergics), pulmonary disorders, and smoking history were collected using the American Thoracic Society questionnaire ([@r11]).

Spirometric tests were performed following a strict protocol in accordance with American Thoracic Society guidelines, as previously reported ([@r42]). Spirometry was assessed in the standing position with a noseclip using a 10-L water-filled survey-recording spirometer and an Eagle II minicomputer (Warren E. Collins, Braintree, MA, USA). Values were adjusted by body temperature and pressure. A minimum of three acceptable spirograms was obtained, of which at least two were reproducible within 5% for both FVC and FEV~1~. Each technician underwent training before taking measurements for this study.

Methacholine challenge tests were conducted between 1984 and 2000 using procedures adapted from [@r9]. We used data from the most recent test available for each subject at that visit. Participants with ischemic heart disease or baseline FEV~1~ \< 60% of the predicted value were excluded, and some elected not to participate. Methacholine inhalations were administered at incremental doses corresponding to 0, 0.330, 1.98, 8.58, 16.8, and 49.8 μmol. Participants whose FEV~1~ declined by 20% in response to any of the doses at or before 8.58 μmol were classified as having airway hyperresponsiveness. Participants whose FEV~1~ did not decline by 20% in response to any of the administered doses, and participants who demonstrated a 20% decline in FEV~1~ at higher methacholine dosages (16.8 or 49.8 μmol) only were categorized as having no airway hyperresponsiveness.

*DNA methylation*. DNA was extracted from stored frozen buffy coat of 7 mL whole blood, using QiAmp DNA blood kits (QIAGEN; <http://www.qiagen.com>). DNA methylation was quantitated using bisulfite-polymerase chain reaction and pyrosequencing ([@r46]) within or nearby the promoter regions of a total of nine genes: Carnitine O-acetyltransferase (*CRAT*), coagulation factor-3 (*F3*), glucocorticoid receptor (*GCR*), intercellular adhesion molecule (*ICAM1*), interferon-gamma (*IFN-*γ), interleukin-6 (*IL6*), inducible nitric oxide synthase (*iNOS*), 8-oxoguanine DNA glycosylase 1 (*OGG1*), and toll-like receptor 2 (*TLR2*). Primers and conditions were previously described ([@r24]). These genes were selected because they are expressed in leukocytes ([@r1]) and are related to cardiorespiratory health, inflammation, and oxidative stress mechanisms ([@r24]; [@r32]; [@r39]). The promoter regions were located using Genomatix Software (Genomatix Software Inc., Ann Arbor, MI, USA) (see Supplemental Material, Table S1). For each gene, we measured 1--5 CpG sites (positions) located within or outside of CpG islands. DNA methylation analysis was repeated on each sample, and results were averaged to reduce assay variability. We used non-CpG cytosine residues as built-in controls to verify bisulfite conversion. The degree of methylation was expressed for each DNA locus as percent methylated cytosines over the sum of methylated and unmethylated cytosines. Because of assay failure and limited amounts of DNA available from each subject, DNA methylation analysis was successful on varying numbers of subjects for each sequence. All samples were analyzed consecutively by one laboratory technician.

*Environmental measurements*. Exposure to urban background pollution was estimated using fixed monitoring stations. Ambient concentrations of black carbon (BC) and of particles with aerodynamic diameter ≤ 2.5 μm (PM~2.5~) were measured hourly at Harvard Supersite, positioned at the top of a building located \< 1 km from the medical center, where the participants' visits took place. BC concentrations were measured using an aethalometer (Magee Scientific Inc., Berkeley, CA, USA), and PM~2.5~ mass concentrations were measured using a Tapered Element Oscillating Microbalance (TEOM model 1400A; Rupprecht and Patashnick Co., East Greenbush, NY, USA). TEOM measurements were corrected for loss of semivolatile particles during sampling, using a collocated gravimetric sampler. About 10% of hourly missing measurements for BC and PM~2.5~ were imputed through a linear regression, where each pollutant was regressed against season, long-term time trend, day of the week, mean temperature, relative humidity, barometric pressure, extinction coefficient, and previous and following day measurements of the pollutant ([@r50]). We regressed hourly PM~2.5~ concentrations against BC (mainly contributed by traffic sources in Boston) and used the residuals as a surrogate measure of nontraffic PM~2.5~ ([@r38]). Hourly carbon monoxide (CO), ozone (O~3~), and nitrogen dioxide (NO~2~) concentrations were measured by local state monitors (four monitors for CO and O~3~, five for NO~2~) and averaged over all monitors. The median distance of the participant homes was 20.8 km to the BC and PM~2.5~ monitoring site, and 20.2, 22.3, and 21.4 km, respectively, for the CO, O~3~, and NO~2~ monitors. We obtained temperature and relative humidity data from the National Weather Service Station at Logan Airport (Boston, MA, USA), located aproximately 12 km from the examination site.

Daily averages were calculated when at least 75% of the hourly values for a given day were available. For each pollutant concentration, we considered a range of short-term and subchronic exposure windows preceding each subject's examination, including: 4 hr, 24 hr (lag 0), previous day (lag 1), and 3, 7, 14, and 28-day moving averages. Because all visits were scheduled for the morning, exposure windows were calculated from 0800 hours the day of the visit.

*Statistical analysis*. We studied the effects of air pollutants on lung function using a mixed linear model. Separate models were run for each pollutant, exposure window, and lung function measurement:

*Y~it~* = β~0~ + *u~i~* + β~1~ Air pollutant*~it~* + β~2~ X~2~*~it~* + ... + β*~p~*X*~pit~* + ε*~it~*, \[1\]

where *Y~it~* was the log-transformed lung function measurement for participant *i* at visit *t*, β~0~ was the intercept, *u~i~* was the random effect, β~1~ was the effect of the air pollutant on lung function measurement, *X*~2~*~it~* to *X~pit~* were the *p*--1 covariates, and ε~it~ was the within-participant error. We selected the following adjustment covariates *a priori* and added a quadratic term whenever it was significant: age (linear and quadratic), ln(height) (linear and quadratic) and standardized weight (linear), race, education level, smoking status, cumulative smoking in pack-years, season of the medical examination (using sine and cosine of time), day of the week, visit number, temperature and relative humidity (matched on air pollutant exposure window), physician-diagnosed chronic lung conditions (asthma, emphysema, chronic bronchitis), methacholine responsiveness, medication use. Because participants with chronic lung conditions are expected to be sicker than average, we explored potential modification of air pollution effects (28-day moving average) by emphysema, chronic bronchitis, methacholine responsiveness (as an objective indicator of asthma), and chronic obstructive pulmonary disease \[COPD; defined as GOLD (Global Initiative for Chronic Obstructive Lung Disease) stage II (FEV~1~/FVC \< 70% and FEV~1~ \< 80% predicted) or higher\].

Several sensitivity analyses were performed. First, we adjusted models for cardiovascular diseases (coronary heart diseases, stroke), diabetes, and hypertension. Next, we excluded participants with physician-diagnosed asthma, emphysema, or chronic bronchitis, and participants with methacholine responsiveness. Finally, to adjust for the fact that healthier men are more likely to come back for subsequent visits, we applied inverse probability weighting ([@r16]) using logistic regression to calculate the probability of having a subsequent visit given age, education level, body mass index, smoking status, pack-years, hypertension, cholesterol, diabetes, FEV~1~, asthma, emphysema, chronic bronchitis, methacholine responsiveness, and air pollutant concentration at previous visit. When estimating interactions between DNA methylation and pollutants, we repeated analyses excluding subjects with chronic lung conditions or taking lung-related drugs (corticosteroids, sympathomimetic α and β, anticholinergics).

We then investigated whether DNA methylation in selected genes influences susceptibility by modeling interactions between 28-day moving average air pollutant concentrations and methylation at individual CpG sites (26 total sites over 9 genes), with methylation dichotomized as high or low at each site based on the median of the distribution ([Table 1](#t1){ref-type="table"}). In addition, we estimated interactions with high or low methylation based on the average over all CpG sites within each gene. Because methylation of long interspersed nucleotide elements (LINE-1) and Alu repetitive elements has been associated with lung function ([@r22]), we also modeled interaction of LINE-1 and Alu methylation (dichotomized as high or low based on the median of the distribution) with air pollutant concentrations as a secondary analysis. LINE-1 and Alu methylation each were measured in three replicates and averaged for statistical analysis.

###### 

Blood DNA methylation levels (percentage of 5-methylcytosine) in 1,515 visits, the Normative Aging Study, 1999--2009.

  Gene and position   *n*     DNA methylation (mean ± SD)   Percentile         
  ------------------- ------- ----------------------------- ------------ ----- ------
  *CRAT*              1,411                                                    
  Position 1                  1.7 ± 0.6                     1.0          1.7   2.6
  Position 2                  4.7 ± 1.6                     2.4          4.6   7.7
  Mean                        3.2 ± 1.0                     1.7          3.2   5.1
  *F3*                1,273                                                    
  Position 1                  1.5 ± 1.8                     0.0          1.2   4.2
  Position 2                  1.6 ± 1.9                     0.0          1.2   4.6
  Position 3                  3.0 ± 2.2                     0.0          2.5   6.9
  Position 4                  1.4 ± 1.6                     0.0          1.1   3.9
  Position 5                  4.5 ± 2.6                     0.0          4.2   8.5
  Mean                        2.4 ± 1.3                     0.9          2.2   4.5
  *GCR*               1,283                                                    
  Position 1                  47 ± 6                        36           47    55
  *ICAM*              1,173                                                    
  Position 1                  5.8 ± 2.3                     2.9          5.5   10.3
  Position 2                  3.5 ± 2.2                     1.7          3.0   9.2
  Position 3                  3.8 ± 2.0                     1.7          3.3   7.3
  Mean                        4.4 ± 1.8                     2.3          4.0   8.1
  *IFN-*γ             1,460                                                    
  Position 1                  82 ± 6                        72           84    90
  Position 2                  87 ± 5                        80           88    93
  Mean                        85 ± 5                        76           86    91
  *IL6*               1,469                                                    
  Position 1                  47 ± 12                       27           47    66
  Position 2                  40 ± 11                       22           40    58
  Mean                        43 ± 10                       26           44    62
  *iNOS*              1,017                                                    
  Position 1                  53 ± 8                        39           53    66
  Position 2                  83 ± 9                        65           85    97
  Mean                        68 ± 7                        55           69    79
  *OGG1*              915                                                      
  Position 1                  2.1 ± 2.6                     0.0          1.2   7.4
  Position 2                  2.9 ± 2.6                     0.0          2.3   8.3
  Position 3                  2.2 ± 2.0                     0.0          1.9   6.1
  Position 4                  2.0 ± 2.2                     0.0          1.5   6.5
  Mean                        2.3 ± 1.4                     0.7          1.9   4.9
  *TLR2*              1,172                                                    
  Position 1                  2.8 ± 1.8                     0.0          2.5   6.1
  Position 2                  3.5 ± 2.0                     0.0          3.3   7.1
  Position 3                  2.9 ± 2.0                     0.0          2.6   6.3
  Position 4                  3.7 ± 2.1                     0.0          3.4   7.3
  Position 5                  2.0 ± 1.9                     0.0          1.8   5.6
  Mean                        3.0 ± 1.3                     1.2          2.7   5.4

Air pollution, DNA methylation, and lung function were all time-varying variables. Models were also adjusted for the percentage of neutrophils, lymphocytes, basophils, eosinophils, and monocytes measured at each visit. Possible mediation of the effects of air pollution on lung function through DNA methylation was tested separately by including DNA methylation variables in the model for the main effects (Equation 1).

*p*-Values \< 0.05 were considered statistically significant. All statistical analyses were conducted with SAS version 9.2 (SAS Institute Inc., Cary, NC, USA).

Results
=======

*Descriptive results*. Participants were mainly white, well educated, and former smokers ([Table 2](#t2){ref-type="table"}). At first visit, 88% of them were ≥ 65 years old. Spearman correlation between FVC and FEV~1~ was 0.90. Air pollutant concentrations were relatively low in terms of particles, with an average of 0.9 ± 0.4 μg/m^3^ for BC and 11 ± 7 μg/m^3^ for total PM~2.5~ ([Table 3](#t3){ref-type="table"}). BC concentrations explained 34% of the PM~2.5~ variability, suggesting that the remaining part was explained by nontraffic sources. The correlation between PM~2.5~ residuals and CO was low (*r*~S~ = 0.12). Because CO is a marker of traffic pollution, this low correlation confirms that BC accounts for most of the variability due to traffic PM~2.5~, and that the PM~2.5~ residuals are a marker of nontraffic particles.

###### 

Characteristics of 776 men, the Normative Aging Study, 1999--2009.

  Characteristic                                                               Value
  ---------------------------------------------------------------------------- -------------
  Participant characteristics at 1st visit                                     
  Age (years)                                                                  72.3 ± 6.8
  Race                                                                         
  Black                                                                        14 (1.8)
  White                                                                        754 (97.2)
  Missing                                                                      8 (1.0)
  Height (cm)                                                                  173.5 ± 7.0
  Weight (kg)                                                                  85.3 ± 14.3
  Education (years)                                                            
  \< 12                                                                        30 (3.9)
  12                                                                           187 (24.1)
  13--15                                                                       219 (28.2)
  \> 15                                                                        333 (42.9)
  Missing                                                                      7 (0.9)
  Smoking status                                                               
  Never                                                                        220 (28.3)
  Current                                                                      33 (4.3)
  Former                                                                       523 (67.4)
  Pack-years^*a*^                                                              21.6 ± 26.8
  Asthma                                                                       46 (5.9)
  Chronic bronchitis                                                           53 (6.8)
  Emphysema                                                                    29 (3.7)
  Methacholine responsiveness                                                  74 (9.5)
  Missing                                                                      125 (16.1)
  Corticosteroids                                                              53 (6.8)
  Sympathomimetic (α, β)                                                       56 (7.2)
  Anticholinergic                                                              14 (1.8)
  FVC (L)                                                                      3.3 ± 0.7
  FEV~1~ (L 1st sec)                                                           2.5 ± 0.6
  Visit characteristics (*n*= 1,515)                                           
  Season                                                                       
  Spring (March--May)                                                          350 (23.1)
  Summer (June--August)                                                        430 (28.4)
  Fall (September--November)                                                   490 (32.3)
  Winter (December--February)                                                  245 (16.2)
  Day of the week                                                              
  Tuesday                                                                      71 (4.7)
  Wednesday                                                                    394 (26.0)
  Thursday                                                                     824 (54.4)
  Friday                                                                       226 (14.9)
  Visit number                                                                 
  1                                                                            776 (51.2)
  2                                                                            501 (33.1)
  3                                                                            192 (12.7)
  4                                                                            46 (3.0)
  Values are mean ± SD or *n* (%). ^***a***^Among current or former smokers.   

###### 

Environmental characteristics 24 hr before lung function assessment for 1,515 visits, the Normative Aging Study, 1999--2009.

  Characteristic                                                                                                                                                                                                                                Mean ± SD   5th, 95th Percentiles   IQR   Spearman correlation coefficient                            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- ----------------------- ----- ---------------------------------- -------- -------- ------ ------
  Air pollutant (μg/m^3^)^*a*^                                                                                                                                                                                                                                                                                                                        
  BC                                                                                                                                                                                                                                            0.9 ± 0.4   0.5, 1.1                0.6                                                               
  CO                                                                                                                                                                                                                                            502 ± 285   299, 660                362   0.42                                                        
  NO~2~                                                                                                                                                                                                                                         38 ± 12     30, 45                  15    0.59                               0.62                     
  O~3~                                                                                                                                                                                                                                          47 ± 24     28, 60                  33    --0.21                             --0.29   --0.31          
  PM~2.5~                                                                                                                                                                                                                                       11 ± 7      6, 13                   7     0.70                               0.34     0.52     0.04   
  PM~2.5~ nontraffic^*b*^                                                                                                                                                                                                                       0 ± 5       --3, 1                  5     0.18                               0.12     0.25     0.24   0.80
  Weather                                                                                                                                                                                                                                                                                                                                             
  Temperature (ºC)                                                                                                                                                                                                                              13 ± 9      7, 20                   13                                                                
  Relative humidity (%)                                                                                                                                                                                                                         68 ± 16     56, 81                  25                                                                
  All *p*-values were \< 0.05. ^***a***^Sample sizes were between 1,499 and 1,515, indicating very few missing data. ^***b***^Because nontraffic PM~2.5~ values are the residuals of the regression of PM~2.5~ against BC, the average was 0.                                                                                                         

*Air pollution and lung function*. An interquartile range (IQR) increase in both total and nontraffic PM~2.5~ concentration from the day before lung function measurement (lag 1) to 28-day cumulated exposure was associated with significantly lower FVC by 0.5--2.5% ([Figure 1](#f1){ref-type="fig"}). For BC, only cumulated exposures of 14, 21, and 28 days were significantly associated with FVC, which was 2--5% lower in association with an IQR increase. Significant associations with FEV~1~ were mainly limited to 28-day moving averages for BC, total PM~2.5~ and nontraffic PM~2.5~. As for gases, an IQR increase in CO or NO~2~ concentration from 4- to 28-day moving averages was associated with a significant decrease in FVC by 1--5%; we estimated similar results for FEV~1~, but restricted the analysis to 14- to 28-day moving averages for NO~2~. For all pollutants, estimated effect sizes increased with longer averaging times. BC and NO~2~ had the largest estimated effects on lung function parameters. Associations with IQR increases in 28-day moving average exposures were significantly stronger in participants with emphysema (for BC, PM~2.5~, and NO~2~ with FVC, and for O~3~ and FEV~1~) and in participants with chronic bronchitis (for O~3~ and nontraffic PM~2.5~ with both outcomes, and for PM~2.5~ with FEV~1~) (see Supplemental Material, Table S2).

![Percent difference in FVC and FEV~1~ (and 95% CIs) associated with 1 IQR increase in air pollutant concentration, the Normative Aging Study, 1999--2009. Depending on the pollutant, the number of observations ranged from 1,259 to 1,275. Results were adjusted for age, race, height, weight, education level, smoking status, cumulative smoking, season of the medical examination, day of the week, visit number, temperature, relative humidity, asthma, chronic bronchitis, emphysema, methacholine responsiveness, corticosteroids, sympathomimetic α and β, anticholinergics. The IQR (μg/m^3^) was 0.6 for BC, 362 for CO, 15 for NO~2~, 33 for O~3~, 7 for total PM~2.5~,and 5 for nontraffic PM~2.5~.](ehp.1206458.g001){#f1}

Further adjusting for cardiovascular diseases (40% of participants), diabetes (17%), and hypertension (82%) did not change the results (not shown). When participants with asthma, emphysema, chronic bronchitis, or methacholine responsiveness (or missing) were excluded (*n* = 254), model estimates were generally consistent with the main analysis, although *p*-values were larger. O~3~ exposure over lag 1 and 3- to 5-day moving averages was associated with significantly lower FVC and FEV~1~. With further controlling for potential survival bias using inverse probability weighting, results varied slightly (see Supplemental Material, Figure S1). Associations of BC, CO, and NO~2~ with lung function were stable or stronger. Associations of O~3~, total PM~2.5~, and nontraffic PM~2.5~ with FVC and FEV~1~ were significant for 28-day cumulative exposures only.

*Effect modification by DNA methylation*. Correlations were relatively high for CpG sites in three of four genes with CpG sites measured at two positions (*CRAT*, *IFN-*γ, and *IL6*), and for one of three pairs of CpG sites in *ICAM1* (0.78 *≤ r ≤* 0.81; see Supplemental Material, Table S3). For the three genes with four to five sites evaluated, there was no evidence of strong correlation between CpG sites within the same gene (*r*~S~ *≤* 0.55). With further adjustment for DNA methylation levels as potential mediators, associations between lung function and air pollutants (28-day moving average) stayed in the same direction; *p*-values were slightly larger and sometimes became nonsignificant for some genes such as *OGG1* (data not shown).

Associations between IQR increases in 28-day average air pollutant concentrations and the lung function measures were significantly different between participants with high versus low DNA methylation status at several CpG sites (results for interactions that were significant for at least one outcome are shown in [Figure 2](#f2){ref-type="fig"}; complete results are shown in Supplemental Material, Figure S2).

![Percent difference in (*A*) FVC and (*B*) FEV~1~ (and 95% CIs) associated with 1 IQR increase in air pollutant concentration (28-day moving average) according to the methylation level \[methylation level \< median (circles), methylation level ≥ median (triangles)\], the Normative Aging Study, 1999--2009. Interactions are in black when statistically significant (*p* \< 0.05) and in blue otherwise. Depending on the pollutant and the gene, the number of observations ranged from 767 to 1,208. Results were adjusted for age, race, height, weight, education level, smoking status, cumulative smoking, season of the medical examination, day of the week, visit number, temperature, relative humidity, asthma, chronic bronchitis, emphysema, methacholine responsiveness, corticosteroids, sympathomimetic α and β, anticholinergics, and percent of white blood cells type. The IQR (μg/m^3^) was 0.6 for BC, 362 for CO, 15 for NO~2~, 33 for O~3~, 7 for total PM~2.5~,and 5 for nontraffic PM~2.5~.](ehp.1206458.g002){#f2}

Associations of BC, total PM~2.5~, and nontraffic PM~2.5~ with FVC were significantly stronger among participants with higher methylation at the CpG site measured in *GCR* ([Figure 2](#f2){ref-type="fig"}), and these interactions remained significant when participants with chronic lung conditions or taking lung-related drugs were excluded from the analysis (data not shown). Associations also were significantly stronger among those with higher methylation at one of five CpG sites measured in *F3* (for BC and FVC) and for those with higher methylation at one of two CpG sites measured in *IL6* (for CO and FVC). Associations of total and nontraffic PM~2.5~ with FVC were significantly stronger among participants with lower methylation at one of the five CpG sites in *TLR2* (position 2), whereas the association between NO~2~ and FEV~1~ was significantly stronger among participants with higher CpG methylation at position 5 in *TLR2*. We did not observe any statistically significant modification of air pollution effects by LINE-1 or Alu methylation (results not shown).

Discussion
==========

In the elderly population of males examined in the present study, acute exposure to air pollutants (4 hr, lag 0, lag 1) was generally not significantly associated with lung function, but subchronic exposures to all tested pollutants from 3- to 28-day moving averages were significantly associated with lower FVC and FEV~1~ (1--5% lower per IQR increase in air pollution concentrations). Associations with 28-day moving average exposures were stronger in participants with lower methylation levels in one of five CpG sites evaluated in *TLR2* (position 2), and stronger among participants with higher methylation in *GCR* (one CpG site evaluated), *TLR2* (position 5), *F3* (position 1), and *IL6* (position 2). To our knowledge, this is the first study to report associations of short- to medium-term air pollutant exposures with FVC and FEV~1~ in an elderly population, and the first to report evidence of epigene--environment interactions on lung function measures.

A study performed in the elderly reported a significant negative association between the peak expiratory flow and PM~2.5~ and PM~10~ on the same day and up to 4 lagged days ([@r23]). Epidemiological studies have produced heterogeneous results regarding the lag structure, and very few have explored exposure windows up to 1 month. In adults and schoolchildren, lower FVC and FEV~1~ were associated with increases in CO, NO~2~, PM~10~, and O~3~ from the examination day up to 3 days before ([@r8]; [@r18]; [@r29]; [@r36]). In contrast, other studies in adults have reported no associations of current and previous-day exposures to NO~2~, O~3~, or particles with FEV~1~ or FVC ([@r31]; [@r43]; [@r47]), and/or delayed associations within 3--7 days ([@r4]; [@r10]; [@r17]; [@r43]). In terms of effect estimates, [@r36] reported a decrease of 0.4--0.8% in FVC and FEV~1~ associated with a 10-μg/m^3^ increase in the 4-day cumulated exposure to NO~2~ in never-smoker adults, which is consistent with the 1.1% decrease in FVC we estimated in association with a 15-μg/m^3^ increase in the 4-day NO~2~ moving average. However, such comparisons are usually made difficult by different modeling choices across studies.

Our results suggested mainly adverse effects of traffic pollutants represented by BC, CO, and NO~2~ on lung function, whereas results for nontraffic PM~2.5~ and O~3~ were less clear. In Boston, BC is a marker of traffic particles influenced by both local traffic, with a morning peak, and long-range transported traffic particles ([@r30]). NO~2~, a lower-airway irritant, is mainly a secondary pollutant, which in Boston mostly originates from traffic and regional sources including power plants and vehicular emissions ([@r33]). There is limited physiologic rationale for an association of CO with reduced lung function. In fact, CO is used therapeutically for acute respiratory distress syndrome. Rather, we interpret its association as an indication of traffic co-pollutants such as ultrafine particles, BC, or NO~2~, for which CO could serve as a surrogate. In contrast, controlled exposure to diesel exhaust, rich in BC and NO~x~ (nitrogen oxides), has been shown to produce pulmonary inflammation ([@r34]). Associations with nontraffic PM~2.5~ were attenuated when adjusted for potential survival bias, suggesting that nontraffic PM~2.5~ was not or was only slightly associated with lung function. Although some studies have reported evidence of short-term effects of O~3~ on lung function ([@r8]), others have failed to demonstrate an association ([@r4]). A previous analysis in the Normative Aging Study covering the period 1995--2005 estimated significantly lower FEV~1~ and FVC in association with O~3~ increases ([@r2]). The present analysis with longer follow-up was able to reproduce those results only when participants with chronic lung diseases were excluded. We do not have any biological explanation for this result, but it is in agreement with the results reported by [@r21], who did not find any effect of O~3~ on lung function in adults with preexisting conditions such as asthma and COPD.

There is a growing body of evidence showing that innate immunity response, and particularly TLRs, are implied in pulmonary inflammation ([@r32]). TLRs recognize damage-associated molecular patterns and activate nuclear factor kappa--light-chain-enhancer of activated B cells (NF-κB), which initiate the production of numerous cytokines and host-defense molecules. *TLR2* is expressed primarily in blood leukocytes and lung ([@r51]). Consistent with this, our previous results showed that lower methylation in *TLR2* was associated with decreased lung function ([@r24]). *TLRs* may also be involved in the development of respiratory diseases ([@r40]) and in gene--environment interactions. For instance, a placebo-controlled intervention study conducted in 916 children from the Netherlands reported that *TLR2* variants influenced the susceptibility of developing asthma in response to NO~2~ and PM~2.5~ exposure ([@r20]). By showing that effects of NO~2~, total PM~2.5~, and nontraffic PM~2.5~ on lung function varied significantly according to the methylation status in the promoter region of *TLR2,* our study provides preliminary support for epigenetic modification of susceptibility to effects of air pollution on lung function. We found inconsistent results between position 2 and position 5 for *TLR2.* This may be interpreted as evidence against a causal effect of *TLR*2 on susceptibility. Also, [@r15] have reported that hypomethylated regions in gene promoters are flanked to either side by methylated cytosines. Position 5 in the *TLR2* sequence analyzed may represent a neighboring methylation site not directly involved in *TLR2* gene suppression, yet hypermethylated in active genes.

*GCR* is an antiinflammatory gene strongly related to stress ([@r28]), inflammation ([@r41]), and lung diseases, which encodes a glucocorticoid protein receptor expressed in the lungs ([@r1]). The main ligands of GCR are corticosteroids. Upon ligand binding, the activated GCR can switch on antiinflammatory genes and switch off inflammatory genes that encode signaling molecules and inflammatory receptors, which are regulated by proinflammatory transcription factors such as NF-κB cells and activator protein. Poor glucocorticoid responses related to genetic polymorphisms in *GCR* have been suggested to increase COPD risk and severity ([@r37]). Our results indicated a stronger association between particulate air pollution (BC, PM~2.5~, nontraffic PM~2.5~) and reduced lung function in participants with higher methylation at a CpG site in the *GCR* promoter region.

*F3* encodes coagulation factor III (i.e., tissue factor), a major player in hemostasis. Previous results suggest that the promoter sequence we studied could regulate the gene ([@r26]). We found stronger associations between BC and FVC among individuals with higher methylation at one of five CpG sites measured in *F3*. Similarly, we found stronger associations between CO and FVC among men with higher methylation at one of two CpG sites evaluated in *IL6. IL6* encodes a protein that may act as both pro- and antiinflammatory cytokine and previous results in our cohort did not find any association of *IL6* with lung function ([@r25]).

Altogether, these results suggest that methylation in inflammation- and immunity-related genes might contribute to effect of air pollution. DNA methylation marks are established mainly during early life, and although thought to be a fairly stable measure, DNA methylation has been associated with aging ([@r27]). In our data, almost all associations between air pollutants and lung function remained after adjustment for DNA methylation, which suggests that pulmonary effects of air pollutants were not mediated by methylation. We checked the locations at which we measured DNA methylation on UCSC Genome Build hg19 (<http://genome.ucsc.edu/cgi-bin/hgGateway>). We specifically designed the assays to exclude SNPs (single-nucleotide polymorphisms) from the CpG sites analyzed and the sequences hybridized by the polymerase chain reaction and pyrosequencing primers. However, because dense genotyping data are not available for this study, we cannot exclude effects from SNPs nearby or remotely located relative to the sequence analyzed. We generally observed stronger associations of air pollutants with FVC than with FEV~1~, suggesting that air pollution may affect more of the smaller airways and therefore is associated with restrictive lung diseases. In the elderly, particle clearance might be less efficient or impaired by other dysfunctions. The apparently small effects of air pollution on lung function should not be underestimated because they might be well tolerated by healthy population, but become life threatening for elderly or ill subjects ([@r12]). In addition, repeated occurrences of short-term decrements in lung function and accompanying inflammation may play some role in the development of long-term decrements.

We acknowledge several limitations of our study. First, as often in air pollution studies, we did not account for indoor exposure to air pollutants. Assuming that the elderly have reduced outdoor activities, indoor sources might be a larger contributor to personal exposure than in other populations. Under the assumption that indoor and outdoor particles are identical, errors due to indoor exposures have been shown of Berkson type, which is expected to increase standard errors ([@r52]). If this assumption of identical indoor and outdoor particles does not hold, the estimated effect would generally be biased downward. Another source of measurement error lies in the low spatial resolution of our exposure model, limited to a few monitoring stations for the entire study area. However, short-term effects studies tend to focus on temporal variation rather than spatial variation. Assuming that daily variation in air pollutant concentrations is homogeneous across the study area might have introduced random noise in exposure estimates, which would tend to underestimate the association with lung function. Therefore it is unlikely that any exposure measurement error would bias the effect away from the null, and this might explain the lack of statistical significance of our PM~2.5~-related results. Second, study results were observed in a cohort of elderly men, which may limit the generalizability of our results to similar populations. Third, for the sake of feasibility, we dichotomized DNA methylation at each CpG site to examine interactions with pollutants concentration. Interactions were analyzed for multiple CpG sites, pollutants, and outcomes, and require caution regarding potential false-positive findings. Finally, although we adjusted for the percentage of white blood cell types, we did not have data available for lymphocyte subsets. Therefore, we cannot rule out the possibility that the interactions are with those subset prevalences and not with the methylation per se.

Conclusion
==========

This study adds to the growing body of literature on short- and long-term effects of traffic-related air pollutants mainly studied in children and young adults, by showing that subchronic but not acute exposure is associated with lower lung function in the elderly. As for the mechanisms, alongside previous studies on genetic variation in inflammatory and immunity genes and respiratory impairment susceptibility, our results suggest that epigenetic mechanisms related to inflammation and immunity may also be implicated in these associations.
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=====================
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Click here for additional data file.
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